- AddressUniversity of New South Wales
Associate Professor Shane Thomas (BSc Hons, PhD) received his PhD in 1999 from the University of Sydney. He then undertook his post-doctoral research studies at the Whitaker Cardiovascular Institute, Boston University as an NHMRC CJ Martin Fellow working with Prof. John Keaney studying the reduction and oxidation (redox) reactions and cell signalling pathways underlying endothelial dysfunction during cardiovascular disease. In 2004 he returned to Australia where he established an independent research group at the Centre for Vascular Research, University of New South Wales (UNSW) as an NHMRC RD Wright Career Development Award Fellow. He currently leads the ‘Redox Cell Signalling’ research group housed within the School of Medical Sciences, UNSW. His research group focuses on defining the oxidative reactions and molecular signalling events promoting endothelial dysfunction and inflammatory cardiovascular disease, and the development of new treatments aimed at targeting deleterious oxidative events during disease.